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Safety and reliability of radio frequency identification devices in
magnetic resonance imaging and computed tomography
Abstract
BACKGROUND: Radio Frequency Identification (RFID) devices are becoming more and more
essential for patient safety in hospitals. The purpose of this study was to determine patient safety, data
reliability and signal loss wearing on skin RFID devices during magnetic resonance imaging (MRI) and
computed tomography (CT) scanning.
METHODS: Sixty RFID tags of the type I-Code SLI, 13.56 MHz, ISO 18000-3.1 were tested: Thirty
type 1, an RFID tag with a 76 x 45 mm aluminum-etched antenna and 30 type 2, a tag with a 31 x 14
mm copper-etched antenna. The signal loss, material movement and heat tests were performed in a 1.5 T
and a 3 T MR system. For data integrity, the tags were tested additionally during CT scanning.
Standardized function tests were performed with all transponders before and after all imaging studies.
RESULTS: There was no memory loss or data alteration in the RFID tags after MRI and CT scanning.
Concerning heating (a maximum of 3.6 degrees C) and device movement (below 1 N/kg) no relevant
influence was found. Concerning signal loss (artifacts 2 - 4 mm), interpretability of MR images was
impaired when superficial structures such as skin, subcutaneous tissues or tendons were assessed.
CONCLUSIONS: Patients wearing RFID wristbands are safe in 1.5 T and 3 T MR scanners using
normal operation mode for RF-field. The findings are specific to the RFID tags that underwent testing.
RESEARCH Open Access
Safety and reliability of Radio Frequency
Identification Devices in Magnetic Resonance
Imaging and Computed Tomography
Thomas Steffen1*†, Roger Luechinger2†, Simon Wildermuth4†, Christian Kern3†, Christian Fretz4†, Jochen Lange1†,
Franc H Hetzer1†
Abstract
Background: Radio Frequency Identification (RFID) devices are becoming more and more essential for patient
safety in hospitals. The purpose of this study was to determine patient safety, data reliability and signal loss
wearing on skin RFID devices during magnetic resonance imaging (MRI) and computed tomography (CT) scanning.
Methods: Sixty RFID tags of the type I-Code SLI, 13.56 MHz, ISO 18000-3.1 were tested: Thirty type 1, an RFID tag
with a 76 × 45 mm aluminum-etched antenna and 30 type 2, a tag with a 31 × 14 mm copper-etched antenna.
The signal loss, material movement and heat tests were performed in a 1.5 T and a 3 T MR system. For data
integrity, the tags were tested additionally during CT scanning. Standardized function tests were performed with all
transponders before and after all imaging studies.
Results: There was no memory loss or data alteration in the RFID tags after MRI and CT scanning. Concerning
heating (a maximum of 3.6°C) and device movement (below 1 N/kg) no relevant influence was found. Concerning
signal loss (artifacts 2 - 4 mm), interpretability of MR images was impaired when superficial structures such as skin,
subcutaneous tissues or tendons were assessed.
Conclusions: Patients wearing RFID wristbands are safe in 1.5 T and 3 T MR scanners using normal operation
mode for RF-field. The findings are specific to the RFID tags that underwent testing.
Background
Incorrect patient identification is a common clinical
problem and confusions may have severe consequences,
especially in surgery. Due to the increasing dispersion of
electronic data processing applications in hospitals and
the lack of patient identification in such systems, the
correct determination of identity becomes more impor-
tant than ever in hospitals. The radio frequency identifi-
cation (RFID) technology with tags (transponders) in
wristbands and medical equipment may close this gap
and increase patient safety.
An RFID tag is a microchip attached to an antenna
and usually fashioned in such a way that it can be fixed
to an object. The tag picks up signals from and sends
signals to a reader. Most RFID tags work in a passive
mode without an own source of energy and transmit
signals only on demand from a reader. RFID-systems
work at different frequency bands: the low-frequency
(LF) systems typically work at ranges from 125 - 134.2
kHz, high-frequency (HF) systems work at 13.56 MHz
and transponders at ultra high frequencies (UHF) work
from 868 - 950 MHz or even up to 2.4 GHz.
The first RFID applications for hospitals have recently
been tested successfully and implemented for instance
to track blood bottles, drugs, dispensers and other small
containers or documents. RFID-systems for transfusion
safety have been successfully developed and tested [1-4].
Correct patient identification is still the most important
key element in these processes and should be integrated
in any advanced hospital RFID system beyond simple
logistic applications.* Correspondence: thomas.steffen@kssg.ch
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Initial attempts in the field of human RFID tagging
have been described for disaster victim identification.
The most preferred method there was an embedded
RFID tag in dental prostheses [5,6].
Another implanted system for humans, whereby the
tag is placed under the skin, has been developed and
was approved by the U.S. Food and Drug Administra-
tion (FDA) in 2004. This system called VeriChip™ was
recommended for example for patient identification
[5,7,8]. This implantable device has been successfully
tested as MR conditional up to 7 T in cylindrical sys-
tems. No adverse effects for patients were found in this
small test series of only two implanted devices [8]. How-
ever, the instruction of the device recommends a contin-
uous monitoring of the patient. Therefore, no MRI
should be performed in sedated patients wearing a Veri-
Chip™ device. Ethical issues, such as security of confi-
dential patient data, increased surveillance of staff
activities or concerns about the safety of implantable
RFID tags were raised recently [7-12]. Today, therefore,
the most promising systems of RFID tags for patient
identification in hospitals are tags that are integrated
into a wristband [13,14]. To ensure patient identification
throughout the hospital stay it is unwanted to remove
such an RFID wristband at any time.
During a hospital stay, many patients mounted with an
RFID wristband will need examination by magnetic reso-
nance imaging (MRI) or computed tomography (CT)
scan. The electromagnetic fields of an MRI scanner can
damage electronic devices and CT scans can influence
radio transmitters by electromagnetic radiation.
Therefore, both the chip and antenna of an RFID
device are potentially at risk under MRI and CT exami-
nation since generally all transponders can be destroyed
by certain field forces [15]. It is not clear whether a
patient wearing an RFID device under such conditions
might be at risk by heat and whether relevant impair-
ment of MRI signals occurs when RFID tags are in the
MRI device. Potential risks of MRI on the RFID are
beside the risk of damaging the RFID, magnetic force on
potential ferromagnetic parts in tag and RF heating at
the edges of the conducting materials of the RFID tag.
From CT no risks for the patient are expected, but
radiation could potentially damage the electronics of the
Tag. To our knowledge, only one study has investigated
the influence of MRI on implanted RFID tags [8],
whereas no information about the safety of patients
equipped with RFID wristbands under MRI and CT
scan is available.
Different physical mechanisms could have an adverse
effect on the RFID tags reliability. In case of MRI induced
high voltages from the gradient field but also from the RF
field may damage the RFID tag. In case of CT, the x-ray
may influence the semiconductor structure of the RFID.
The acquired images may be influenced by the RFID.
In case of MRI, slightly different magnetic properties of
the RFID tag may lead to susceptibility artifacts, which
could be seen as signal void or signal distortion next to
the tag. In CT images, the RFID will absorb radiation, if
passing the chip, leading to distorted images.
The aim of this study was to determine the reliability
and data integrity of a certain sort of RFID devices
under the specific conditions during clinical MRI and
CT scans as well as the safety of patients wearing an
RFID wristband. We hypothesize that RFIDs remain
unaffected by MRI or CT examination and that the
impairment of the imaging quality is not relevant in
clinical routine examination.
Methods
Materials
Sixty RFID transponder tags were provided by InfoMe-
dis AG, Alpnach, Switzerland (equipment support). For
the test, passive RFID transponder tags of the type I-
Code SLI, 13.56 MHz, ISO 18000-3.1 (NXP Semicon-
ductors, Graz, Austria) of two different sizes were used
(Figure 1). These specific RFID tags were chosen
because they are commonly used in high volume appli-
cations e.g. libraries, person ID or industrial applica-
tions. Further, a standardized air interface is given and
used worldwide (ISO 18000-3.1; ISO 15693), the tags
provide sufficient memory (> 1 k bit) and they are a low
cost solution with chip prices around USD 0.10 today.
The frequency at 13.56 MHz and the according reading
field are suitable for required near field communication
(Table 1).
Methods
Device function
In order to perform a reliability test with the RFID
transponders, 15 of each of the two types underwent
MRI and CT examination. In groups of five, the RFID
Figure 1 RFID tag (31 × 14 mm, Copper, etched).
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tags were attached to the sides of a 300 × 215 × 80 mm
cardboard box in each of the three dimensions of the
room. A standardized scanning protocol was used dur-
ing MRI and CT scanning under the same conditions as
during a patient examination. The test was performed
twice, therefore a total of 60 tests of RFID tags were
performed. The RIFD tags were tested for function out-
side the MRI room after they were scanned by the MRI
machine because the reader devices contain ferrous
metal.
For this clinical MRI test, a 1.5 T MR system (Avanto;
Siemens Medical Solutions, Erlangen, Germany) was
used and a standard protocol for a cranial examination
was performed. The imaging protocol included trans-
verse T1-weighted gradient-echo (225/4.67; flip angle,
80°) [repetition time msec/echo time msec], fluid-atte-
nuated turbo inversion-recovery (FLAIR) (8500/111/
2500 [repetition time msec/echo time/inversion time
msec], T2-weighted turbo spin-echo (4000/80), diffu-
sion-weighted (4000/102 with b-values of 0, 500, and
1000 sec/mm”) and coronal fat suppressed T2-weighted
turbo inversion-recovery (6000/38/140) sequences. Field
of view was 210 cm; slice thickness was 5 mm with an
intersection gap of 1.5 mm. Pixel size varied between
0.4 × 0.4 mm (T1-weighted images) and 0.8 × 0.8 mm
(FLAIR).
Additionally, in a 3 T MR scanner (Achieva, Philips
Healthcare, Best, The Netherlands) worst case sequences
(high gradient performance, high B1 field and high spe-
cific absorption rate (SAR)) provided by the MR manu-
facturer for third party device testing have been
performed continuously over nearly two hours. Four
RFID tags have been placed to the edges of the field of
view (FOV) where high gradient effects are expected,
and four tags have been placed in the transversal plane
through the isocenter (2 in the isocenter, 2 near the
wall of the scanner bore). Tags have been placed parallel
to the transversal, coronal and sagital imaging planes.
These worst case MR tests have been performed in a 3
T MR system (Achieva, Philips Healthcare, Best, The
Netherlands). The compatibility protocols as required in
the IEC 60601-2-33 [19] to evaluate influences from the
MR equipment on peripheral equipment were used. On
the used scanner the following three sequences have
been provided which have been repeated in all three
orientations. The used scanner limits the whole body
SAR to 0.9 W/kg to stay within the limit of 10 W/kg for
the local SAR. In the research mode this limit has been
disabled and 4 W/kg could be applied. The sequence
called “Max B1+SAR” was a 20 min long turbo spin-
echo (131/6.1) sequence with a whole body SAR of 4
W/kg and a peripheral nerve stimulation (PNS) level of
100%, “MAX Grad” was a 3:30 min long steady-state-
free-precession (2.6/0.99) sequence with a whole body
SAR of 1.6 W/kg and a PNS level of 100%, and “Max
Grad +RF” was a 6:30 min long turbo spin-echo (379/
6.2) sequence with a whole body SAR of 3.9 W/kg and
a PNS level of 100%.
In the CT scan, the exposure time was 44.6 s and a
standard protocol for abdominal CT examination was
performed with a CT technique of 88 mAs at 120 kV,
and a Computed Tomography Dose Index (CTDI) at
6.33 rad.
An operational check was carried out on all RFID tags
with a Feig Obid-MR100 RFID reader (Feig Electronic
GmbH, Weilburg, Germany) before and after the ima-
ging tests performed. Proper function of the RFID tag
was defined by three criteria tested in three steps after
exposure to the MR and CT scan. Firstly, the Unique
Identification Number (UID) of each RFID tag must be
readable without error. Secondly, correct data writing
was tested by error-free programmability of the total
memory area of the RFID tag. Thirdly, impeccable func-
tion of the RFID tag was assumed when the UID and
the content of the variable memory of each RFID tag
was again accurately tested for proper data reading.
Artifact Assessment Signal loss has been assessed in-
vitro (according to the ASTM F2119-07 Standard) and
with in-vivo MRI measurements [16]. Both RFID tags
have been placed one after the other in the middle of
the plastic grid, immersed in 1 g/L CuSO4 solution (Fig-
ure 2). Gradient echo (TR = 100 ms, TE = 15 ms, flip
angle = 30°, BW = 32 kHz) and Spin echo sequences
(TR = 500 ms, TE = 20 ms, BW = 32 kHz) as described
in the ASTM Standard F2119-01 have been performed
in a 3 T whole body Philips Achieva MR system (Philips
Healthcare, Best, The Netherlands). The resolution was
1.4 × 1.4 × 3 mm3 using a 256 × 256 scan matrix.
Five of the small RFID tags were used for in-vivo tests
concerning signal loss. To qualitatively measure the sig-
nal loss, a comparison of images of a wrist with and
without RFID tag in the 1.5 T MR-Scanner (Avanto;
Table 1 RFID tags used in the study
RFID Tag Large
I-Code SLI, 13,56 MHz
Small
I-Code SLI, 13,56 MHz
Chip 1 kbit variable memory, 96 bit UID 1 kbit variable memory, 96 bit UID
Antenna Dimension of antenna: 76 × 45 mm, Aluminium, etched Dimension of antenna: 31 × 14 mm, Copper, etched
UID: Unique Identification Number
Used transponders: I-Code SLI (NXP Semiconductors, Graz, Austria)
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Figure 2 Quantitative image artifacts. Both RFID tags shown on the top have been placed one after the other in the middle of the plastic
grid, immersed in 1 g/L CuSO4 solution. Gradient echo and Spin echo sequences as described in the ASTM Standard F2119-01 have been
performed. The upper row shows MR images of a 3 mm-thick slice through the tags, the middle row slices 5 mm below the tag and the last
row shows an orthogonal slice through the tag. Signal void could be found only a few millimeters away from the tag. Reduced signal due to
shielding of the RF field may produce darker shadows in slices up to 1 cm away.
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Siemens Medical Solutions, Erlangen, Germany) was
performed. In terms of getting a worst case scenario, an
MRI of the wrist of a consenting volunteer was con-
ducted with an RFID tag attached directly to the skin
(Figure 3). The images were compared to examination
results performed without an RFID device. Images were
analyzed qualitatively for signal loss.
Patient safety
All measurements for tissue heating near the RFID tag,
movement and artifacts were carried out on a 1.5 T and
3 T Philips Achieva MR system (Philips Healthcare,
Best, The Netherlands) running software release 2.5.1.
For the heating measurement the build in body coil was
used.
Tissue heating near RFID device
Temperature elevation is based on energy absorption.
The capacity of the chip area to diffuse excessive
energy generated by the antenna of an RFID tag is lim-
ited and therefore RIFD devices can heat up in higher
fields [15]. However, in case of the RF field of a MRI,
heating will also occur due to field distortions and ele-
vations at or close to the metallic parts of the RFID
tag. For heating measurements, the American Society
for Testing and Materials (ASTM)-phantom (Standard
F2182-02a) was used, which was filled with 30 l of
0.45% saline solution [17]. Measuring time was 15
minutes, and as patient weight 75 kg was entered.
Since the RFID tags are not implanted but preferable
wrapped around the wrist, the RFID tags were not
placed inside the liquid as recommended for implants
but placed on the surface of an agar-phantom mimick-
ing the arm of a patient. The agar was made out of the
same saline solution with additional 2% agar as a gel-
ling agent. The similar setup has been used and
described in detail in other contexts [20]. The agar
phantom prevents convection next to the RFID. The
agar-phantom was placed at the right side of the
ASTM-phantom near the scanner bore wall where the
most intense heating is expected. However, this is
highly dependent of the position of the tag with
respect to the rungs of the body resonator (high E-
fields), and thus manufacturer-dependent. Due to
asymmetry of the induced E-fields in the ASTM phan-
tom the side with higher heating has to be determined
with test measurements. It has been verified that the
right side shows more heating effects than the left
side. The RFID were placed 16 cm to the right side of
the tank. A large type RFID tag was placed on the
moistened agar-phantom and two temperature sensors
were placed under the antenna. The entire RFID tag
made contact with the agar gel in order to simulate
the worst-case scenario. The reference sensor was
placed directly on the surface of the agar-phantom and
covered with a thick piece of paper, simulating an
RFID tag with no metallic wires/content. The compari-
son with a placebo RFID in the same measurement
allowed avoiding the known inaccuracy of the SAR
estimation of clinical MR systems [18]. A further sen-
sor was placed approximately 1 cm under the RFID tag
in the agar-phantom. The tank with the RFID was
moved into the scanner until; the RFID was in z-direc-
tion in the isocenter of the body coil. Measurements
were performed with a specific sequence provided by
the MR manufacturer according to the requested high
SAR/B1 sequence in the MR standard IEC 60601-2-33
[19]. This is a Turbo Spin Echo Sequence (TSE) with a
whole-body specific absorption rate (SAR) at 4 W/kg
(1.5 T) and 0.9 W/kg (3 T). The 3 T MR system is
limited to this whole-body SAR due to a local SAR
limit of 10 W/kg. The whole body SAR provided by
the scanner software was verified for the given tank
with a calorimetric measurement and the the measured
values were within 10% of the calculated values for
both field strength. However whole body and local
SAR may strongly vary for different MR systems.
Device movement
Measurements for device movement were performed
with the large and small RFID tags using the 3 T MR
system (Achieva, Philips Healthcare, Best, The Nether-
lands) according to ASTM F2052. This is a test method
that covers the measurement of the magnetically
induced displacement force produced by the static mag-
netic field on medical devices. The main magnetic field
gradient of the MR scanner used at the measurement
point was 45 ± 2 mT/cm (= 4500 mT/m) [20]. It is
located 3 cm away from the laser cross for patient posi-
tioning. Torque effects were assessed qualitatively and if
any torque could be noticed measurements would be
performed.
Figure 3 Two RFIDs attached directly to the skin of a right
wrist in a volunteer with the devices centered in a dedicated
8-channel wrist coil.
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Results
Device function
All of the 60 RFID tags tested showed normal function
after testing with MR and CT scans. All UID could be
read before and after the test with no evidence of loss of
function. Previously saved data could be read correctly
and completely and the memory areas of all tags were
overwritten and read properly. No loss of function or
malfunction was detected. No difference between the
RFID tags tested with MR or CT scan or between the
two different sizes of antennas was found.
Signal loss
Quantitative measurement of MRI signal loss showed
small artifacts of about 2 - 4 mm (Figure 2). The qual-
ity of the images was minimally impaired due to the
tags positioned near the body area examined (Figure
4).
No artifacts were detected in CT images and no influ-
ence of the RFID tags on the image quality was found.
Patient safety
Tissue heating near RFID tag
With the 1.5 T MR system, normalized at 2 W/kg as
required by the International Electreotechnical Commis-
sion (IEC) standard, and using the large tag, a maximum
heating of 3.6°C and 3.0°C at the two different points
under the tag was found after 15 minute of scanning. At
the reference point on the surface of the agar-phantom,
a heating of up to 1.0°C was measured. The RF power
sent to the body coil was 340+-10 W. At the sensor
centered 1 cm below the RFID tag, a maximum heating
of 1.5°C was found. The same tests were performed
with an RFID wristband containing the small RFID tag
and with direct contact of the tag with the temperature
sensor. With the small RFID tag, no temperature rise of
more than 1.5°C was found in any tested configuration.
Figure 5 shows the development of the normalized tem-
perature over time for the worst-case measurement with
the large RFID tag.
Figure 4 Qualitative image artifacts. MR imaging findings in a volunteer with the RFID tags positioned on the dorsum of the wrist (a, b) and
on the volar aspect of the wrist (c, d). Axial T1-weighted spin-echo MR-image (600/13; number of signals acquired, 1; field of view, 90 mm)
shows only minimal geometric distorsion and susceptibility artifacts on skin and underlying subcutaneous tissue (arrowheads) (a and c). Axial T2-
weighted Flash2D gradient-echo MR-image (400/15; number of signals acquired, 2; field of view, 90 mm) shows increased susceptibility artifacts
on skin and underlying subcutaneous tissue and tendons (arrows) (b and d). Interpretation of articular structures is not compromised.
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With the 3 T system all heating measurements were
below 0.8°C (normalized to 2 W/kg). At 3 T, the refer-
ence sensors sometimes showed even more heating than
the sensor next to the RFID tag. The RF power was in
this scanner 90 ± 10 W, since the whole body SAR was
limited to 0.9 W/kg.
Device movement
Accelerations impinging on the RFID tags were all
found to be below 1 N/kg in a magnetic field gradient
of 45 mT/cm, which is far below the limit of 9.8 N/kg
mentioned in the standard ASTM F2052-06e [21]. Such
accelerations are generally not or minimally perceptible
for human beings when an RFID wristband is used.
Even an RFID tag lying on a water surface was mini-
mally moved in the main magnetic field of the 3 T sys-
tem. No torque effects could be found for both tested
tags.
Discussion
This study was performed to evaluate patient safety as
well as the reliability and data integrity of passive RFID
devices under clinical conditions with MRI and CT
scan. Passive RFID devices are likely to be used for
applications with RFID wristbands for patient identifica-
tion. Such patient identification is central to many other
RFID-related processes in hospitals.
For the first time, we were able to show that the RFID
tags used in this study sustained no damage after being
exposed to typical everyday conditions during CT or
MR examination. Reading and saving data was unaltered
after clinical MRI or CT scans. Moreover, patient safety
was not impaired by wearing an RFID wristband during
MRI or CT examinations.
Within the last few years, the use of autoidentification
technologies has rapidly entered the hospital environ-
ment [21]. A number of RFID applications have been
implemented in hospitals so far, mostly for logistic pur-
poses such as material tracking or inventory manage-
ment, according to the original applications of the
technology [2,21-23]. Only recently, more complex
applications have been implemented in hospitals, for
example in patient-care management processes such as
blood transfusion or the prevention of wrong side sur-
gery [1,3,13,24-27]. RFID technology seems ideal for
complex environments like hospitals since the technol-
ogy itself is to be applied for more gainful and differen-
tiated applications. In this context, it was shown that
autoidentification systems, ideally implemented as RFID
applications, can contribute to improving efficiency and
patient safety [28-30].
To ensure the proper functioning of passive RFID
devices, it must be shown that no memory alterations
occur and thus the ability to operate after exposure to
electromagnetic fields is crucial. For the use of RFID
tags in MRI systems, it is a precondition that they must
not contain any ferromagnetic material. Our tags con-
tained etched aluminum and copper, respectively, which
we consider to be the important factor in finding no
device movements in our tests.
All transponders had been scanned and re-written
successfully each time. The large version of the tags has
a 50% longer range to be read and can be used for
instance as personal badges, for equipment or docu-
ments. They were tested due to their larger antenna
area and consequently greater potential for energy
absorption than smaller-sized RFID tags. This means
that two parameters were altered in this test. The size of
the antenna as well as the metal (copper in the small
version and aluminum in the large version) of the RFID
tags. However, no RFID tag failed in the tests.
Ferromagnetic metals are used in low-frequency RFID
tags (<148.5 kHz), which are not likely to be used for
Figure 5 Tissue heating near RFID tag, temperature development over time. Temperature increases next to the large RFID tag at different
positions during an MR sequence in a 1.5 T whole-body MR scanner. The temperature increases have been normalized to 2 W/kg as requested
by the ASTM Standard.
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the purposes described here. We used RFID tags work-
ing at 13.56 MHz because these tags are considered the
most appropriate for use in a hospital environment.
Today, 1.5 T MR systems operating with a frequency of
64 MHz are standard; however, low-field systems with
0.5 T or even 0.3 T operate at a frequency near that
used in the RFID system tested (13.56 MHz). For these
low-field systems, interference is very likely but was not
tested in this study! The results presented are limited to
1.5 T and 3 T MR scanners.
The quantitative measurement showed only very small
artifacts of 2 - 4 mm in size. These are minor artifacts
compared to the artifacts caused by implants and do not
lead to impairment of the image quality. However, we
recommend not placing an RFID tag directly on the
region of interest in MRI examinations (e.g. skin lesion,
malignant melanoma).
According to the ASTM standard, a device is consid-
ered as MR safe if it causes no known hazards to patients
in all MR environments. Since the RFID tag contains
conducting materials, RFID may only be MR conditional,
meaning be safe under certain conditions for MR ima-
ging during the scan. Significant increasing of tempera-
ture and unexpected strong movements are potential risk
factors for patients with an implant during MRI examina-
tion. As for the measured heating of the RFID device
during MRI examination, a maximum rise in temperature
of about 4°C on the skin surface is not harmful, in the
normal operating mode of the MR scanner. In clinical
examinations, the rise in temperature would even be
reduced by the cooling effect due to sweating, air convec-
tion, blood circulation and perfusion [31].
Furthermore, our results regarding device movement
showed that such concerns are irrelevant with less than
1 N/kg for MRI examinations in MRI scanners with
field strength of up to 3 T in patients wearing an RFID
wristband. No torque effects could be seen.
Although the types of RFID tags tested in our study
are those most likely to be used in hospitals, we are
aware of the fact that there is a huge market of different
types of RFID tags. These other types of RFID tags need
to be tested in different MR conditions and also under
other clinical conditions. Given that we used passive
RFID tags, no statement can be made about active RFID
tags under the clinical conditions described. However,
the utilization of the much cheaper passive RFID tags in
hospitals is much more likely than the more expensive
active tags.
Conclusion
Wristbands for patient identification equipped with
RFID transponders not containing ferromagnetic com-
ponents do not have to be removed for MRI and CT
scanning. This ensures that patient identification is
guaranteed without interruption and no data loss is
expected.
We conclude that patients wearing RFID wristbands
are safe in 1.5 T and 3 T MR scanners using normal
operation mode for RF-field, when the types of tags
tested here are used. Our conclusions pertain specifically
to the RFID tags that underwent evaluation.
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